Last reviewed · How we verify
NCT00383344
Use of FDG PET/CT to Evaluate Crohn Disease
Phase 2 trial testing FDG PET/CT in Crohn Disease in 30 participants. Completed in 1 May 2007.
1 May 2007
Quick facts
| Lead sponsor | Eric Turcotte |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 30 |
| Start date | 1 October 2006 |
| Primary completion | 1 May 2007 |
| Estimated completion | 1 May 2007 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- FDG PET/CT
Conditions studied
- Crohn Disease — all drugs for Crohn Disease →
Sponsor
Eric Turcotte
Who can join
18 and older, any sex, with Crohn Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study will permit to determine the role of FDG PET/CT to diagnose Crohn Disease and recurrence of Crohn disease after having compared results of PET/CT's with results of exams routinely performed(colonoscopy and bowel follow through).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00383344
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FDG PET/CT
Trials testing the same drug.
- NCT05654675 — Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET · recruiting
- NCT05000138 — FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis · completed
- NCT04614116 — Cold Induced Futile Cycles In White Adipose Tissue · NA · completed
- NCT04271436 — Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT · Phase 2 · withdrawn
- NCT04685798 — Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparati · NA · terminated
Other recruiting trials for Crohn Disease
Currently open trials in the same condition.
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07310095 — A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) · Phase 4 · recruiting
- NCT07364734 — Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease · recruiting
- NCT07170462 — Cranberry and Gut Health in Crohn's Disease · EARLY_PHASE1 · recruiting
- NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease · Phase 2, PHASE3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00383344 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eric Turcotte
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00383344.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing